| 41.76 1.265 (3.12%) | 12-08 13:14 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 48.6  |
1-year : | 56.76 |
| Resists | First : | 41.61 |
Second : | 48.6 |
| Pivot price | 37.09 |
|||
| Supports | First : | 36.28 |
Second : | 32.99 |
| MAs | MA(5) : | 40.08 |
MA(20) : | 36.89 |
| MA(100) : | 32.36 |
MA(250) : | 0 | |
| MACD | MACD : | 1.8 |
Signal : | 1.4 |
| %K %D | K(14,3) : | 92.5 |
D(3) : | 92.9 |
| RSI | RSI(14): 73.9 |
|||
| 52-week | High : | 47.68 | Low : | 22.65 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ OMCL ] has closed below upper band by 4.4%. Bollinger Bands are 135.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 41.01 - 41.2 | 41.2 - 41.39 |
| Low: | 38.91 - 39.13 | 39.13 - 39.34 |
| Close: | 40.13 - 40.48 | 40.48 - 40.81 |
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Mon, 08 Dec 2025
Omnicell, Inc. Launches Omnicell Titan XT Automated Dispensing System - TradingView
Mon, 08 Dec 2025
Omnicell (NASDAQ: OMCL) launches Titan XT ADS for cloud-based, enterprise medication management - Stock Titan
Mon, 08 Dec 2025
Omnicell (OMCL) Valuation Check After Recent Share Price Rebound - Yahoo Finance
Fri, 05 Dec 2025
Insider Sell: Corey Manley Sells Shares of Omnicell Inc (OMCL) - GuruFocus
Fri, 05 Dec 2025
Reasons to Add Omnicell Stock to Your Portfolio Right Now - cnhinews.com
Mon, 01 Dec 2025
Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 45 (M) |
| Shares Float | 44 (M) |
| Held by Insiders | 1.8 (%) |
| Held by Institutions | 103 (%) |
| Shares Short | 2,180 (K) |
| Shares Short P.Month | 1,930 (K) |
| EPS | 0.43 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 27.2 |
| Profit Margin | 1.6 % |
| Operating Margin | 2.6 % |
| Return on Assets (ttm) | 0.5 % |
| Return on Equity (ttm) | 1.6 % |
| Qtrly Rev. Growth | 10 % |
| Gross Profit (p.s.) | 11.49 |
| Sales Per Share | 26.29 |
| EBITDA (p.s.) | 1.67 |
| Qtrly Earnings Growth | -36 % |
| Operating Cash Flow | 153 (M) |
| Levered Free Cash Flow | 107 (M) |
| PE Ratio | 96.23 |
| PEG Ratio | 0 |
| Price to Book value | 1.52 |
| Price to Sales | 1.57 |
| Price to Cash Flow | 12.11 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|